Latest filing published 04 Jun 2024 for Fusion Pharmaceuticals Inc..
No signal scores available.
This profile gathers the share dealings of Mohit Rawat in Fusion Pharmaceuticals Inc. Over a trading history stretching from 31 August 2023 to 4 June 2024, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 4 June 2024 came the latest disclosure, a transaction in Fusion Pharmaceuticals Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations